RAGHX vs. FPHAX
Compare and contrast key facts about Virtus Health Sciences Fund (RAGHX) and Fidelity Select Pharmaceuticals Portfolio (FPHAX).
RAGHX is managed by Allianz. It was launched on Feb 4, 2002. FPHAX is managed by Fidelity. It was launched on Jun 17, 2001.
Performance
RAGHX vs. FPHAX - Performance Comparison
Loading graphics...
RAGHX vs. FPHAX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
RAGHX Virtus Health Sciences Fund | -9.13% | 7.23% | -2.33% | 2.57% | -11.64% | 25.44% | 13.76% | 26.69% | 4.37% | 17.33% |
FPHAX Fidelity Select Pharmaceuticals Portfolio | 0.39% | 30.41% | 9.39% | 12.54% | 0.94% | 11.79% | 11.16% | 31.73% | 5.41% | 10.70% |
Returns By Period
In the year-to-date period, RAGHX achieves a -9.13% return, which is significantly lower than FPHAX's 0.39% return. Over the past 10 years, RAGHX has underperformed FPHAX with an annualized return of 6.97%, while FPHAX has yielded a comparatively higher 11.27% annualized return.
RAGHX
- 1D
- 2.24%
- 1M
- -8.95%
- YTD
- -9.13%
- 6M
- -0.59%
- 1Y
- 0.22%
- 3Y*
- -0.85%
- 5Y*
- 0.92%
- 10Y*
- 6.97%
FPHAX
- 1D
- 3.02%
- 1M
- -5.31%
- YTD
- 0.39%
- 6M
- 13.18%
- 1Y
- 34.09%
- 3Y*
- 17.36%
- 5Y*
- 12.54%
- 10Y*
- 11.27%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
RAGHX vs. FPHAX - Expense Ratio Comparison
RAGHX has a 1.37% expense ratio, which is higher than FPHAX's 0.75% expense ratio.
Return for Risk
RAGHX vs. FPHAX — Risk / Return Rank
RAGHX
FPHAX
RAGHX vs. FPHAX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Virtus Health Sciences Fund (RAGHX) and Fidelity Select Pharmaceuticals Portfolio (FPHAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| RAGHX | FPHAX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.06 | 1.33 | -1.39 |
Sortino ratioReturn per unit of downside risk | 0.05 | 1.84 | -1.79 |
Omega ratioGain probability vs. loss probability | 1.01 | 1.24 | -0.23 |
Calmar ratioReturn relative to maximum drawdown | -0.04 | 2.50 | -2.54 |
Martin ratioReturn relative to average drawdown | -0.12 | 7.03 | -7.15 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| RAGHX | FPHAX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.06 | 1.33 | -1.39 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.06 | 0.71 | -0.65 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.40 | 0.64 | -0.23 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.48 | 0.53 | -0.05 |
Correlation
The correlation between RAGHX and FPHAX is 0.86, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
RAGHX vs. FPHAX - Dividend Comparison
RAGHX has not paid dividends to shareholders, while FPHAX's dividend yield for the trailing twelve months is around 5.66%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
RAGHX Virtus Health Sciences Fund | 0.00% | 0.00% | 0.00% | 0.00% | 9.51% | 21.85% | 14.50% | 6.89% | 16.12% | 0.00% | 0.00% | 23.19% |
FPHAX Fidelity Select Pharmaceuticals Portfolio | 5.66% | 5.68% | 1.90% | 8.08% | 5.18% | 11.09% | 8.85% | 8.33% | 1.65% | 1.62% | 1.07% | 12.63% |
Drawdowns
RAGHX vs. FPHAX - Drawdown Comparison
The maximum RAGHX drawdown since its inception was -40.23%, which is greater than FPHAX's maximum drawdown of -38.26%. Use the drawdown chart below to compare losses from any high point for RAGHX and FPHAX.
Loading graphics...
Drawdown Indicators
| RAGHX | FPHAX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -40.23% | -38.26% | -1.97% |
Max Drawdown (1Y)Largest decline over 1 year | -14.48% | -11.00% | -3.48% |
Max Drawdown (5Y)Largest decline over 5 years | -22.14% | -28.82% | +6.68% |
Max Drawdown (10Y)Largest decline over 10 years | -28.01% | -28.82% | +0.81% |
Current DrawdownCurrent decline from peak | -14.25% | -7.10% | -7.15% |
Average DrawdownAverage peak-to-trough decline | -7.06% | -9.21% | +2.15% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.79% | 4.30% | +0.49% |
Volatility
RAGHX vs. FPHAX - Volatility Comparison
The current volatility for Virtus Health Sciences Fund (RAGHX) is 5.66%, while Fidelity Select Pharmaceuticals Portfolio (FPHAX) has a volatility of 6.89%. This indicates that RAGHX experiences smaller price fluctuations and is considered to be less risky than FPHAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| RAGHX | FPHAX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.66% | 6.89% | -1.23% |
Volatility (6M)Calculated over the trailing 6-month period | 11.56% | 14.30% | -2.74% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.45% | 23.52% | -4.07% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 16.40% | 17.74% | -1.34% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.46% | 17.81% | -0.35% |